0 items USD 0.00Search
Your search for "technavio global acquired orphan blood diseases therapeutics market 2015 2019" gave back 48391 results.
The global Acquired Orphan Blood Diseases Therapeutics market size was valued at US$ 908 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Acquired Orphan Blood Disease market size was valued at US$ million in 2023. With growing demand in downstream market, the Acquired Orphan...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Biologics manufacturing or Biomanufacturing is primarily a recombinant DNA technology based complex process of manufacturing biopharmaceuticals using...
Catalog:
IQ4I
September 2020
Price: USD 4,950.00
Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Still's Disease Treatment market was valued at US$ 1785.2 million in 2023 and is anticipated to reach US$ 2513.5 million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global Still's Disease Treatment market size was valued at US$ 1746.3 million in 2023. With growing demand in downstream market, the Still...
Catalog:
LPI
February 2024
Price: USD 3,660.00
